文献速递乳房整形与再造创面修复

乳房再造与手臂淋巴水肿发生风险:一项Meta分析

Breast reconstruction and risk of arm lymphedema development: A meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-02-21

该系统综述与Meta分析检索PubMed(1966-2016)、Embase(1966-2016)、Scopus(2004-2016)和Google Scholar(2004-2016),纳入19项研究(基于患者数7501例或手术乳房数2063例),评估乳房再造与淋巴水肿的关联。结果显示乳房再造与淋巴水肿风险降低显著相关(p < 0.001),假体再造与自体再造之间淋巴水肿发生率无统计学显著差异。作者认为该关联可能源于多因素,需进一步前瞻性研究。

要点

  • 乳房再造与淋巴水肿风险降低显著相关(p < 0.001)。
  • 假体再造与自体再造的淋巴水肿发生率无统计学显著差异。
  • 作者认为该关联可能源于多因素,需进一步前瞻性研究。

核心结论

  • 乳房再造与仅行乳房切除或保乳手术的患者相比,淋巴水肿发生率更低。
  • 该研究不能证明因果关系,作者假设该关联可能源于自我选择人群及乳房再造可能参与淋巴水肿一级或二级预防的机制。
  • 作者认为需要进一步前瞻性研究来阐明乳房再造与淋巴水肿风险降低之间的有益关系。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed(1966-2016)、Embase(1966-2016)、Scopus(2004-2016)和Google Scholar(2004-2016)。
  • 初检获得934篇文章,筛选后纳入19项研究,基于患者数(7501例)或手术治疗的乳房数(2063例)评估结局。
  • 因研究间存在异质性,采用随机效应模型进行Meta分析。

主要发现

  • 乳房再造与仅行乳房切除或保乳手术相比,淋巴水肿的比值显著更低(p < 0.001)。
  • 接受假体再造与自体再造的患者之间,淋巴水肿发生率无统计学显著差异。

关键数值与推荐

  • 主要结局为淋巴水肿发生。
  • 乳房再造与淋巴水肿风险降低显著相关(p < 0.001)。
  • 假体再造与自体再造的淋巴水肿发生率无统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该研究不能证明因果关系。
  • 作者认为需要进一步前瞻性研究来阐明乳房再造与淋巴水肿风险降低之间的有益关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphedema remains a significant complication following breast cancer surgery when there is axillary lymph node intervention. Previous systematic reviews have identified risk factors for breast cancer-related lymphedema, including increased BMI, number of lymph nodes dissected and radiotherapy. However, they have not examined the effect of breast reconstruction on lymphedema occurrence. In this systematic review and meta-analysis, we sought to evaluate the association between breast reconstruction (BR) and lymphedema. METHODS: We searched PubMed (1966-2016), Embase (1966-2016), Scopus (2004-2016) and Google Scholar (2004-2016) for studies involving breast reconstruction and upper-extremity lymphedema or breast cancer-related lymphedema. Our primary outcome was lymphedema occurrence. We performed a meta-analysis using random effects due to heterogeneity of the studies. RESULTS: Our search strategy identified 934 articles. After screening, 19 studies were included in our meta-analysis evaluating outcomes based on number of patients (7501) or number of breasts surgically treated (2063). Breast reconstruction was significantly associated with lower odds of lymphedema (p < 0.001) compared to mastectomy only or breast-conserving surgery. Lymphedema rates were not statistically significantly different between patients undergoing implant-based or autologous BR. CONCLUSIONS: Breast reconstruction is associated with lower rates of lymphedema compared to mastectomy only or breast conserving surgery patients. Although the study does not prove causation, we hypothesize that this association is likely due to multiple factors, including a self-selecting population and mechanisms through which BR may contribute to primary or secondary prevention of lymphedema. Further prospective studies are needed to clarify this beneficial relationship between breast reconstruction and reduced lymphedema risk.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Siotos C, Sebai ME, Wan EL, et al. Breast reconstruction and risk of arm lymphedema development: A meta-analysis. J Plast Reconstr Aesthet Surg. 2018. PMID: 29475791. doi:10.1016/j.bjps.2018.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。